Interestingly, the performance of the CRM-Multi model was comparable (or worse) to that of the CM model while several studies demonstrated that the clinical–radiomics combined model showed higher performance than the clinical or radiomics model alone for predicting clinically significant PCa and BCR-free survival [81,82]. This evidence concerns the gene BCR and posterior cortical atrophy.